Should We Be Screening for SARS-CoV-2 in IBD Patients before Initiation of Biologic Therapy?
Loading...
Files
Date
Journal Title
Journal ISSN
Volume Title
Publisher
Oxford University Press
Abstract
Description
Keywords
Biological therapy, Covid-19, Ibd, Sars-cov-2, Covid-19 testing, Humans, Inflammatory bowel diseases, Azathioprine, Budesonide, Corticosteroid, Methotrexate, Prednisone, Tofacitinib, Tumor necrosis factor inhibitor, Ustekinumab, Clinical practice, Coronavirus disease 2019, Enzyme linked immunosorbent assay, High risk patient, Human, Humoral immunity, Infection risk, Inflammatory bowel disease, Lung lavage, Nonhuman, Outcome assessment, Personalized medicine, Practice guideline, Reverse transcription polymerase chain reaction, Review, Screening test, Sensitivity analysis, Severe acute respiratory syndrome coronavirus 2, Viral clearance, Virus gene, Virus shedding, Adverse event, Diagnosis, Procedures, Virology